ArticleBMC cancer2022

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients.

Yoshiya Horimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.